drugset / Trial / NCT05698407

Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia

NCT05698407

Phase 4 Completed 200 enrolled Peking University First Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

Sufentanil-ropivacaine combination is commonly used for epidural labor anesthesia, but is associated with some adverse events. Dexmedetomidine is a high selective alpha2-adrenoceptor agonist. Mounting evidences show that dexmedetomidine-ropivacaine combination can also be used effectively for epidural labor analgesia. This pilot trial is designed to compare the effect of dexmedetomidine-ropivacaine combination versus sufentanil-ropivacaine combination on neonatal outcomes when used for epidural labor analgesia, and to test the feasibility of a future large randomized trial.

Timeline

Start
2023-03-16
Primary completion
2023-06-15
Completion
2023-08-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.36 ug/ml Other
Comparator Sufentanil Other / unclassified 0.36 ug/ml Other
Background Ropivacaine Other / unclassified 0.07 % Other

Indications